Journal of cardiac failure
Journal of cardiac failure
Audio Summaries
Every issue of Journal of cardiac failure moves the field forward, but reading every paper cover-to-cover isn't realistic. OSLR turns each article into a 3-minute audio summary so you can stay current while you commute, round, or work out.
Recent summaries
The latest articles summarized from Journal of cardiac failure.
Heart Transplantation in 2076: Evolution, Transformation, or Obsolescence?
Sep 8, 2026
The authors explore the future of heart transplantation by 2076, questioning whether it will evolve, transform, or become obsolete due to advancements in immune tolerance, xenotransplantation, and bioengineered organs. They suggest that while donor-dependent transplantation may still exist, it will be part of a broader array of heart-replacement strategies tailored to individual needs and contexts. Ultimately, the focus will shift from early survival rates to long-term functional independence and equitable access to diverse therapeutic options.
Beyond Tacrolimus: Toward Personalized Immunosuppression in Heart Transplantation
Sep 8, 2026
The authors investigate the potential for personalized immunosuppression in heart transplantation, addressing the limitations of current regimens that lack individualization despite variability in recipient characteristics. They explore advancements in immune monitoring and biomarkers, propose a framework for integrating these tools into patient management, and suggest future directions, including innovative technologies and trial designs needed to enhance personalized approaches in this field.
From Innocence to Endurance: A Patient's Perspective on Lifelong Transplant Care
Sep 8, 2026
This article presents the personal journey of Malik Wellington, who reflects on his experiences with lifelong transplant care following his first heart transplant at age 17 and subsequent health challenges, including cancer diagnoses. The narrative explores the impact of chronic immunosuppression on his health and life trajectory, culminating in a second heart and kidney transplant 24 years later. The author aims to provide insights into the patient perspective on enduring the complexities of transplant care and the resilience required to navigate these challenges.
Extracorporeal Photopheresis in Heart Transplantation: From Salvage Therapy to Immunosuppression-Sparing Strategy
Sep 8, 2026
The authors investigate the role of extracorporeal photopheresis (ECP) in heart transplantation, questioning its potential as an immunosuppression-sparing strategy amidst challenges like acute and chronic rejection. They review the immunologic mechanisms, clinical evidence, and applications of ECP, emphasizing its safety and underutilization, particularly in high-risk patients. The paper also identifies knowledge gaps and proposes future research directions to better define ECP's role in contemporary transplant practices.
The Future of Donor Heart Preservation
Sep 8, 2026
The authors investigate advancements in donor heart preservation technologies aimed at expanding the donor pool and improving graft viability. They discuss various methods, including controlled hypothermia, normothermic ex vivo perfusion, and hypothermic oxygenated perfusion, highlighting their potential to enhance preservation times and reduce organ injury. Ultimately, the paper explores how these innovations could increase access to heart transplantation by allowing for the use of extended-criteria and donation after circulatory death donors.
Heart Transplantation in 2076: From Scarcity to Cardiac Restoration
Sep 8, 2026
The authors explore how the paradigm of heart transplantation may evolve by 2076, moving away from reliance on donor organs towards innovative cardiac restoration strategies. They examine advancements in molecular diagnostics, regenerative therapies, and artificial intelligence that could enhance heart failure care and promote equity in treatment. Ultimately, the paper envisions a future where heart failure management includes a diverse array of approaches, reducing the dependence on traditional transplantation methods.
Circulating Dipeptidyl Peptidase 3 levels, an Antagonist of Angiotensin-(1-7), in Acute Heart Failure: Insights from the PUSH-AHF trial
Sep 4, 2026
The authors aimed to investigate the levels of circulating dipeptidyl peptidase 3 (cDPP3) in patients with acute heart failure and their association with clinical characteristics, decongestive response, and outcomes. They found that higher cDPP3 concentrations were linked to impaired kidney function and reduced diuretic response, while natriuresis-guided therapy improved decongestion across different cDPP3 levels. The study suggests that further research is needed to clarify the clinical significance of cDPP3 in acute heart failure.
Body Composition in Heart Failure: A Phenotype-Informed Framework for Assessment and Management
Sep 4, 2026
The authors investigate how body composition metrics, particularly BMI and waist-based indices, relate to outcomes in heart failure (HF) patients, noting that traditional measures may not accurately reflect the complexities of body composition in this population. They propose a phenotype-informed framework that distinguishes between different biological profiles associated with adiposity, fluid retention, and muscle integrity, suggesting that this approach could enhance risk stratification and management strategies for HF patients. Ultimately, the framework aims to improve understanding of how similar BMI values can correspond to varying clinical risks and outcomes.
From Rescue to Interception: The PREVENT 2-LATE Framework for Advanced Heart Failure
Aug 27, 2026
The authors aim to address the challenge of timely referral for advanced heart failure therapies by proposing the PREVENT 2-LATE framework, which identifies patients earlier in their disease trajectory using specific clinical signals. This framework emphasizes a multidisciplinary approach to proactively manage patients before they reach critical stages, thereby preserving treatment options and improving long-term outcomes. Additionally, the paper consolidates best practices for left ventricular assist device (LVAD) management to enhance clinician confidence and optimize patient care.
Development and Independent Validation of a Machine Learning-Based Non-Invasive Venous Waveform Analysis for Heart Failure (NIVA<sub>HF</sub>) Device to Estimate Pulmonary Capillary Wedge Pressure
Aug 21, 2026
The authors aimed to develop and validate a machine learning-based device, NIVA<sub>HF</sub>, for non-invasively estimating pulmonary capillary wedge pressure (PCWP) from peripheral venous waveforms in heart failure patients. In a multicenter study, they found that the NIVA Score showed a mean bias of -1.06 mmHg compared to invasively measured PCWP, indicating good agreement and high sensitivity for detecting elevated filling pressures. This suggests that NIVA<sub>HF</sub> could serve as a valuable non-invasive tool for monitoring congestion in heart failure management.